ArticleDiscover oncology2025
The safety and efficacy of atezolizumab for recurrent primary liver cancer after liver transplantation.
Rong-Rong Yao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it